Stacey L. Bjorgaard

Statistics

Publications

Citations

3.4K

H-Index

Active since

2017

Affiliations

Massachusetts Institute of Technology(Current)

Massachusetts General Hospital

Broad Institute

Harvard University

The University of Texas MD Anderson Cancer Center

Stacey L. Bjorgaard is an author at Massachusetts Institute of Technology specializing in tumor immunology, cancer immunology, and immune checkpoint inhibitors.

Publications per year

2017–2019

Publications

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text

Life Sciences, Immunology, Oncology +14

Resistance to checkpoint blockade therapy through inactivation of antigen presentation

Moshe Sade-Feldman, Yunxin J. Jiao, Jonathan Chen et al. · Nature Communications · 2017 · 1K citations · Full text

Medicine, Immunology, Oncology +17

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

Vivek Verma, Rajeev Shrimali, Shamim Ahmad et al. · Nature Immunology · 2019 · 333 citations · Full text

Life Sciences, Immunology, Oncology +17

1–3 of 3